Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 481

Results For "CHI"

5488 News Found

AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
Healthcare | February 04, 2022

AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day

It has signed an MoU with Plan India to expand its reach to Karnataka


Mylab launches CoviSwift for Covid-19 Point of Care testing
Medical Device | February 03, 2022

Mylab launches CoviSwift for Covid-19 Point of Care testing

Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals


Pristyn Care doubles it surgical centres to 800 in 2021
Startup | February 03, 2022

Pristyn Care doubles it surgical centres to 800 in 2021

Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost


Granules receives ANDA approval for anti-depressant medication
Drug Approval | February 03, 2022

Granules receives ANDA approval for anti-depressant medication

It has a total of 50 ANDA approvals from USFDA


Dr. Reddy's set to acquire Nimbus Health
News | February 03, 2022

Dr. Reddy's set to acquire Nimbus Health

The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients


More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun
interviews | February 02, 2022

More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun

Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health


Moderna’s Covid-19 `Spikevax’ vaccine gets full USFDA approval
Biotech | February 01, 2022

Moderna’s Covid-19 `Spikevax’ vaccine gets full USFDA approval

Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel


CAS launches major biology expansion
Digitisation | February 01, 2022

CAS launches major biology expansion

The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists


Alembic receives USFDA approval for clarithromycin tablets
Drug Approval | February 01, 2022

Alembic receives USFDA approval for clarithromycin tablets

Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA


Budget 22-23: Healthcare sector applauds focus on mental health
News | February 01, 2022

Budget 22-23: Healthcare sector applauds focus on mental health

A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook